Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Here is Why Growth Investors Should Buy Haemonetics (HAE) Now
02:29pm, Thursday, 09'th Mar 2023
Haemonetics (HAE) could produce exceptional returns because of its solid growth attributes.
Haemonetics (HAE) Autotransfusion System Gets 510(k) Clearance
11:18am, Friday, 03'rd Mar 2023
The latest development is expected to upgrade Haemonetics' (HAE) Cell Salvage platform and broaden the company's scope in the growing autotransfusion space.
Haemonetics Executing Well, But Valuation Dogged By Concerns About A Large Customer
09:00pm, Wednesday, 15'th Feb 2023
Haemonetics surpassed sell-side expectations with healthy revenue growth from Plasma and Hospital, but margin leverage was lacking due to the ongoing impact of inflation and supply chain issues. The c
Bull of the Day: Haemonetics (HAE)
09:47am, Wednesday, 15'th Feb 2023
Leader in blood management for hospitals see estimates and price targets rise after strong quarter
New Strong Buy Stocks for February 10th
08:17am, Friday, 10'th Feb 2023
SNEX, DTEGY, CLVT, HAE and ARCC have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2022.
Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term
11:20am, Thursday, 09'th Feb 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Haemonetics (HAE) Q3 Earnings Beat Estimates, Margins Down
10:34am, Thursday, 09'th Feb 2023
In the fiscal third quarter, Haemonetics (HAE) incurs higher research and development costs, primarily due to increased investments in product innovation.
3 Medical Products Stocks Navigating Industry Challenges
09:48am, Thursday, 09'th Feb 2023
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, ZBH and HAE are well-poised
HAE Stock: 5.95% Decrease Explanation
05:21pm, Tuesday, 07'th Feb 2023
The stock price of Haemonetics Corporation (NYSE: HAE) fell by 5.95% in the most recent trading session. This is why.
Haemonetics Corporation (HAE) Q3 2023 Earnings Call Transcript
02:17pm, Tuesday, 07'th Feb 2023
Haemonetics Corporation (NYSE:HAE ) Q3 2023 Earnings Conference Call February 7, 2023 8:00 AM ET Company Participants David Trenk - Manager, Investor Relations Chris Simon - Chief Executive Officer Ro
Incyte, Haemonetics Post Earnings Beats; One Surges Within Buy Zone
10:05am, Tuesday, 07'th Feb 2023
Incyte stock fell Tuesday after topping quarterly expectations, while fellow medical outlet Haemonetics leapt on its own beat-and-raise. The post Incyte, Haemonetics Post Earnings Beats; One Surges Wi
Haemonetics (HAE) Q3 Earnings and Revenues Surpass Estimates
09:02am, Tuesday, 07'th Feb 2023
Haemonetics (HAE) delivered earnings and revenue surprises of 7.59% and 4.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics: Earnings Rate Of Change Justifies High Multiples
10:00am, Wednesday, 01'st Feb 2023
Haemonetics continues to catch a strong bid in FY23' having clipped a 74% gain over the past 12 months. The earnings return on invested capital ultimately justifies this, following HAE's cost restruct
Looking for a Growth Stock? 3 Reasons Why Haemonetics (HAE) is a Solid Choice
02:01pm, Tuesday, 31'st Jan 2023
Haemonetics (HAE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
What Makes Haemonetics (HAE) a Strong Momentum Stock: Buy Now?
01:33pm, Friday, 27'th Jan 2023
Does Haemonetics (HAE) have what it takes to be a top stock pick for momentum investors? Let's find out.
